摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(5-methylimidazol-4-yl)-4,4,5,5-tetramethyl-2-imidazoline-1-oxyl | 627846-05-3

中文名称
——
中文别名
——
英文名称
2-(5-methylimidazol-4-yl)-4,4,5,5-tetramethyl-2-imidazoline-1-oxyl
英文别名
IM-MeImz
2-(5-methylimidazol-4-yl)-4,4,5,5-tetramethyl-2-imidazoline-1-oxyl化学式
CAS
627846-05-3
化学式
C11H17N4O
mdl
——
分子量
221.282
InChiKey
QWUQKWCCUUCLKI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    16
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.64
  • 拓扑面积:
    45.3
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    manganese(II) chloride tetrahydrate 、 2-(5-methylimidazol-4-yl)-4,4,5,5-tetramethyl-2-imidazoline-1-oxylpotassium thioacyanate乙醇 为溶剂, 生成 Mn(IM-MeImz)2(SCN)2*3H2O
    参考文献:
    名称:
    Ferromagnetic behavior of nickel(II) and manganese(II) complexes with IM-MeImz-κ2 N, O mode
    摘要:
    Two complexes of formulas [Ni(IM-Melmz)(2)(SCN)(2)]center dot CH3CH2OH (1) and [Mn(IM-Melmz)(2)(SCN)(2)]-3H2O (2), where IM-Melmz=2-(5-Methylimidazol-4-yl)-4,4,5,5-tetramethyl-2-imidazoline-1-oxyl, have been synthesized and characterized by single-crystal X-ray diffraction. The X-ray analysis demonstrates that IM-Melmz ligand is coordinated to metal ion with the kappa(2) N(Melmz), O(IM) mode to avoid steric hindrance with the methyl group in complex. In the solid state, the complexes 1 and 2 are linked by intermolecular hydrogen bonds, leading to two-dimensional structure. The variable-temperature magnetic susceptibility of both compounds suggests that the metal ions and radicals are ferromagnetically coupled with J = 2.78 and 1.11 cm(-1) for complexes I and 2, respectively. (C) 2008 Published by Elsevier B.V.
    DOI:
    10.1016/j.molstruc.2007.07.025
点击查看最新优质反应信息

文献信息

  • Synthesis, Crystal Structures and Magnetic Properties of Copper(II) Complexes with Nitronyl Nitroxide Radicals
    作者:Yu-Fang Wang、Li-Ya Wang、Lu-Fang Ma
    DOI:10.1002/zaac.200700322
    日期:2008.1
    Two new copper(II) compounds with imino nitroxide radicals [Cu(IM-MeImz)2 · (SCN)] 0.5[Cu(SCN)4] (1) and [Cu(IM-MeImz)2 · (SCN)]ClO4 · H2O (2) (IM-meImz = 2-(5-methylimidazol-4-yl)-4,4,5,5-tetramethyl-2-imidazoline-1-oxyl) have been synthesized and characterized structurally and magnetically. X-ray analysis demonstrates that complex 1 contains CuII ions in both square-pyramidal and square planar coordination
    两种具有亚氨基氮氧自由基的新型铜 (II) 化合物 [Cu(IM-MeImz)2 · (SCN)] 0.5[Cu(SCN)4] (1) 和 [Cu(IM-MeImz)2 · (SCN)]ClO4 · H2O (2) (IM-meImz = 2-(5-methylimidazol-4-yl)-4,4,5,5-tetramethyl-2-imidazoline-1-oxyl) 已被合成和表征结构和磁性。X 射线分析表明配合物 1 包含方形锥体和方形平面配位中的 CuII 离子。电荷完全分离为 [Cu(IM-MeImz)2(SCN)]+ 阳离子和 0.5[Cu(SCN)4]- 阴离子,比例为 2:1。配合物1通过分子间相互作用连接为一维聚合物。在配合物 2 中,铜原子周围的配位是扭曲的四方锥体,顶端位置被 SCN- 阴离子的一个氮原子占据。二维网络结构是通过分子间氢键相互作用形成和排列的。配合物
  • Ferromagnetic behavior of nickel(II) and manganese(II) complexes with IM-MeImz-κ2 N, O mode
    作者:Yu-fang Wang、Li-ya Wang、Lu-fang Ma
    DOI:10.1016/j.molstruc.2007.07.025
    日期:2008.4
    Two complexes of formulas [Ni(IM-Melmz)(2)(SCN)(2)]center dot CH3CH2OH (1) and [Mn(IM-Melmz)(2)(SCN)(2)]-3H2O (2), where IM-Melmz=2-(5-Methylimidazol-4-yl)-4,4,5,5-tetramethyl-2-imidazoline-1-oxyl, have been synthesized and characterized by single-crystal X-ray diffraction. The X-ray analysis demonstrates that IM-Melmz ligand is coordinated to metal ion with the kappa(2) N(Melmz), O(IM) mode to avoid steric hindrance with the methyl group in complex. In the solid state, the complexes 1 and 2 are linked by intermolecular hydrogen bonds, leading to two-dimensional structure. The variable-temperature magnetic susceptibility of both compounds suggests that the metal ions and radicals are ferromagnetically coupled with J = 2.78 and 1.11 cm(-1) for complexes I and 2, respectively. (C) 2008 Published by Elsevier B.V.
查看更多

同类化合物

辛基羟乙基咪唑啉 辛基羟乙基咪唑啉 肉豆蔻基羟乙基咪唑啉 甲基-(1-甲基-吡咯烷-2-亚基)-胺 甲基(5-甲基-1,2-恶唑-3-基)氨基甲酸酯 油基胺乙基咪唑啉 氯代醋酸钠与4,5-二氢-十一烷基-1H-咪唑-1-乙醇和氢氧化钠的反应产物 月桂基羟乙基咪唑啉 恶唑-4-基氨基甲酸叔丁酯 异硬脂基羟乙基咪唑啉 异噁隆 异丙基亚氨基吡咯烷 噻唑-2,4-二胺 噁唑-4-胺 叔-丁基2-氨基-6,7-二氢吡唑并[1,5-A]吡嗪-5(4H)-甲酸基酯 十七碳-2-烯基-4,5-二氢-1H-咪唑-1-乙醇盐酸盐 偶氮引发剂VA-064 依凡达明 二氨基吡唑 乙基3-(乙基氨基)-5-甲基-1,2-恶唑-4-羧酸酯 alpha-(氯甲基)-2-异丙基-5-硝基-2H-咪唑-2-乙醇 alpha,4,4-三甲基-2-十一烷基-2-咪唑啉-1-乙醇 Z-2-(8-十七烯基)-4,5-二氢-1H-咪唑-1-乙醇 N-甲基-3-氨基吡唑 N-甲基-2-吡咯烷酮肟 N-甲基-1,2-噻唑-3-胺1,1-二氧化物 N-环己基-1,2-噻唑-3-胺1,1-二氧化物 N-叔-丁基-5-甲基-2H-吡唑-3-胺 N-乙基-N-(5-甲基-3-异恶唑基)-乙酰胺 N-乙基-1,2-噻唑-3-胺1,1-二氧化物 N-乙基-1,2,5-恶二唑-3,4-二胺 N-[2-[2-[(E)-十七碳-8-烯基]-4,5-二氢咪唑-1-基]乙基]乙烷-1,2-二胺 N-[2-[2-(13-二十一碳烯-1-基)-4,5-二氢-1H-咪唑-1-基]乙基]乙二胺 N-[2-(4,5-二氢-2-十九烷基-1H-咪唑-1-基)乙基]乙二胺 N-[2-(4,5-二氢-2-十一烷基-1H-咪唑-1-基)乙基]乙二胺 N-[(2Z)-哌嗪-2-亚基]-2,2,2-三氟乙酰肼 N-[(2-甲基苯基)氨基甲硫杂酰]-2-(4-羰基-2-苯基喹唑啉-3(4H)-基)-3-苯基丙酰胺 N-BOC-4-氨基噻唑 N-3-异恶唑氨基甲酸叔丁酯 N-(噻二唑-4-基)氨基甲酸乙酯 N-(5-叔丁基-1H-吡唑-3-基)氨基甲酸甲酯 N-(4,5-二甲基-3-异噁唑)氨基甲酸1,1-二甲基乙酯 N-(2-氨基乙基)-N'-[2-[2-(13-二十一碳烯基)-4,5-二氢-1H-咪唑-1-基]乙基]乙二胺 N-(2-氨基乙基)-N'-[2-(4,5-二氢-2-十九烷基-1H-咪唑-1-基)乙基]乙二胺 N-(2-氨基乙基)-N'-[2-(2-十七烷基-4,5-二氢-1H-咪唑-1-基)乙基]乙二胺 N,N,N',N'-四甲基-4,6-二(三甲基硅烷基)环戊二烯并[c]吡咯-1,3-二胺 N,N,N',N',5-戊甲基环戊并[c]吡咯-1,3-二胺 N,N,3,3-四甲基氮杂环丙烯-2-胺 N,5-二甲基-1,2-恶唑-3-胺 6H-吡唑并[1,5-c][1,2,3]三唑-3,5,6-三胺